We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Hit With $2.5M Verdict In 1st Philly Risperdal Trial

Law360, Philadelphia (February 24, 2015, 2:25 PM EST) -- A Philadelphia jury slapped a Johnson & Johnson unit with $2.5 million in damages on Tuesday in the first verdict over the antipsychotic drug Risperdal's connections to abnormal breast growth in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.